| Abivax Sa | 1.8M | US$240M | 11.0% |
| Protagonist Therapeutics, Inc. | 961K | US$118M | 5.4% |
| Roivant Sciences Ltd. | 3.16M | US$112M | 5.1% |
| Immunovant, Inc. | 2.33M | US$89.8M | 4.1% |
| Zai Lab Ltd. | 3.37M | US$64M | 2.9% |
| Agios Pharmaceuticals, Inc. | 1.29M | US$47.8M | 2.2% |
| Crinetics Pharmaceuticals, Inc. | 1.22M | US$45.7M | 2.1% |
| Cytokinetics, Incorporated | 458K | US$39M | 1.8% |
| Septerna, Inc. | 941K | US$31.5M | 1.4% |
| Anteris Technologies Global Corp. | 3.15M | US$31M | 1.4% |
| Editas Medicine, Inc. | 8.89M | US$28.8M | 1.3% |
| Denali Therapeutics Inc. | 1.03M | US$26.5M | 1.2% |
| Spyre Therapeutics, Inc. | 284K | US$25.2M | 1.2% |
| Vir Biotechnology, Inc. | 2.46M | US$25M | 1.1% |
| Praxis Precision Medicines, Inc. | 74,253 | US$24.9M | 1.1% |
| Insmed Incorporated | 229K | US$24.4M | 1.1% |
| Celldex Therapeutics, Inc. | 620K | US$23.1M | 1.1% |
| Viking Therapeutics, Inc. | 574K | US$22.4M | 1.0% |
| Taysha Gene Therapies, Inc. | 3.04M | US$20.7M | 0.95% |
| Monopar Therapeutics Inc. | 218K | US$20.1M | 0.92% |
| Ovid Therapeutics Inc. | 7.42M | US$20M | 0.91% |
| Enliven Therapeutics, Inc. | 388K | US$19.7M | 0.90% |
| Enanta Pharmaceuticals, Inc. | 1.34M | US$19.6M | 0.90% |
| Nektar Therapeutics | 244K | US$17M | 0.78% |
| Inspire Medical Systems, Inc. | 375K | US$16.7M | 0.76% |
| Revolution Medicines, Inc. | 87,509 | US$16.4M | 0.75% |
| Establishment Labs Holdings Inc. | 186K | US$15.9M | 0.73% |
| Rhythm Pharmaceuticals, Inc. | 136K | US$15.1M | 0.69% |
| Inhibikase Therapeutics, Inc. | 7.39M | US$15M | 0.69% |
| Rallybio Corporation | 926K | US$14.8M | 0.68% |
| Regeneron Pharmaceuticals, Inc. | 22,208 | US$13.8M | 0.63% |
| Inventiva Sa | 3.61M | US$13.6M | 0.62% |
| Sutro Biopharma, Inc. | 404K | US$13.4M | 0.61% |
| Ionis Pharmaceuticals, Inc. | 166K | US$13.2M | 0.60% |
| Bridgebio Pharma, Inc. | 177K | US$13.2M | 0.60% |
| Sarepta Therapeutics, Inc. | 731K | US$13.1M | 0.60% |
| Cytomx Therapeutics, Inc. | 3.37M | US$12.6M | 0.58% |
| Vor Biopharma Inc. | 681K | US$12.5M | 0.57% |
| Equillium, Inc. | 3.76M | US$12M | 0.55% |
| Climb Bio, Inc. | 823K | US$10.7M | 0.49% |
| Helix Acquisition Corp. Iii | 1M | US$10.6M | 0.49% |
| Zura Bio Limited | 1.76M | US$10.4M | 0.48% |
| Onkure Therapeutics, Inc. | 2.24M | US$10.2M | 0.47% |
| Maze Therapeutics, Inc. | 339K | US$10.1M | 0.46% |
| Xenon Pharmaceuticals Inc. | 167K | US$10.1M | 0.46% |
| Teva Pharmaceutical Industries Limited | 278K | US$9.41M | 0.43% |
| Sensei Biotherapeutics, Inc. | 361K | US$9.03M | 0.41% |
| Amylyx Pharmaceuticals, Inc. | 494K | US$8.88M | 0.41% |
| Dbv Technologies Sa | 528K | US$8.66M | 0.40% |
| Savara, Inc. | 1.4M | US$8.64M | 0.40% |
| Vaxcyte, Inc. | 146K | US$8.49M | 0.39% |
| Cg Oncology, Inc. | 119K | US$8.43M | 0.39% |
| Mineralys Therapeutics, Inc. | 299K | US$8.06M | 0.37% |
| Amanat Acquisition Corp | 750K | US$7.62M | 0.35% |
| Nurix Therapeutics, Inc. | 313K | US$7.6M | 0.35% |
| Biohaven Ltd. | 502K | US$7.47M | 0.34% |
| Prime Medicine, Inc. | 2M | US$7.37M | 0.34% |
| Perceptive Capital Solutions Corp | 675K | US$7.34M | 0.34% |
| Opus Genetics, Inc. | 1.78M | US$7.33M | 0.34% |
| Lexeo Therapeutics, Inc. | 1.57M | US$7.29M | 0.33% |
| Damora Therapeutics, Inc. | 280K | US$7.28M | 0.33% |
| Replimune Group, Inc. | 656K | US$7.26M | 0.33% |
| Leonabio, Inc. | 777K | US$7.14M | 0.33% |
| Korro Bio, Inc. | 540K | US$7.12M | 0.33% |
| Research Alliance Corporation Iii | 650K | US$6.96M | 0.32% |
| Relay Therapeutics, Inc. | 358K | US$6.7M | 0.31% |
| Janux Therapeutics, Inc. | 421K | US$6.46M | 0.30% |
| Pliant Therapeutics, Inc. | 5.51M | US$6.28M | 0.29% |
| Whitehawk Therapeutics, Inc. | 1.34M | US$6.14M | 0.28% |
| Krystal Biotech, Inc. | 16,420 | US$6.1M | 0.28% |
| Arbutus Biopharma Corporation | 1.27M | US$6.09M | 0.28% |
| Pfizer, Inc. | 252K | US$6.08M | 0.28% |
| Brighthouse Financial, Inc. | 95,523 | US$6.05M | 0.28% |
| Edgewise Therapeutics, Inc. | 143K | US$5.82M | 0.27% |
| Alector, Inc. | 2.88M | US$5.8M | 0.27% |
| Fulcrum Therapeutics, Inc. | 1.57M | US$5.73M | 0.26% |
| Arrowhead Pharmaceuticals, Inc. | 69,800 | US$5.69M | 0.26% |
| Acumen Pharmaceuticals, Inc. | 2.11M | US$5.64M | 0.26% |
| Globus Medical, Inc. | 70,100 | US$5.54M | 0.25% |
| Monte Rosa Therapeutics, Inc. | 217K | US$5.25M | 0.24% |
| Danaher Corporation | 25,932 | US$4.94M | 0.23% |
| Boundless Bio, Inc. | 1.97M | US$4.92M | 0.23% |
| Avalyn Pharma Inc. | 146K | US$4.82M | 0.22% |
| Ars Pharmaceuticals, Inc. | 601K | US$4.81M | 0.22% |
| Ataibeckley Inc. | 913K | US$4.81M | 0.22% |
| Prelude Therapeutics Incorporated | 901K | US$4.8M | 0.22% |
| Jatt Ii Acquisition Corp | 418K | US$4.75M | 0.22% |
| Rein Therapeutics, Inc. | 4.5M | US$4.68M | 0.21% |
| Pepgen Inc. | 2.59M | US$4.66M | 0.21% |
| Contineum Therapeutics, Inc. | 279K | US$4.57M | 0.21% |
| Perspective Therapeutics, Inc. | 1.21M | US$4.13M | 0.19% |
| Apogee Therapeutics, Inc. | 31,000 | US$4.11M | 0.19% |
| Corbus Pharmaceuticals Holdings, Inc. | 422K | US$3.96M | 0.18% |
| Biogen Inc. | 17,900 | US$3.87M | 0.18% |
| Xencor, Inc. | 233K | US$3.74M | 0.17% |
| Spruce Biosciences, Inc. | 67,717 | US$3.66M | 0.17% |
| Palisade Bio, Inc. | 1.73M | US$3.61M | 0.17% |
| Protara Therapeutics, Inc. | 941K | US$3.59M | 0.16% |
| Sagimet Biosciences Inc. - Series A | 438K | US$3.38M | 0.15% |
| Beone Medicines Ltd. Class A | 11,701 | US$3.33M | 0.15% |